An asprosin-deficient rat strain would be particularly helpful and could be combined with the known metabolic models (such as the spontaneously hypertensive, Dahl salt sensitive hypertensive and Zucker diabetic strains and obesogenic protocols) to explore the role of asprosin and fibrillin in metabolic syndrome. This evidence concerns the gene FBN1 and metabolic syndrome.